Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?2011 · 127 citations
2. 2Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology2009 · 933 citations
3. 3The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa2012 · 160 citations
4. 4Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa2013 · 40 citations
5. 5Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?2011 · 65 citations